Company HTG Molecular Diagnostics Inc Nasdaq
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- | - |
2023 | Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc. | CI |
2023 | Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc. | CI |
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Consumables
49.3
%
| 4 | 42.5 % | 3 | 49.3 % | -17.07% |
Research Use Only Sample Processing
40.8
%
| 4 | 41.4 % | 3 | 40.8 % | -29.56% |
Instruments
9.6
%
| 1 | 15.6 % | 1 | 9.6 % | -56.00% |
Custom Research Use Only Assay Design
0.3
%
| 0 | 0.5 % | 0 | 0.3 % | -58.63% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
65.1
%
| 6 | 69.0 % | 4 | 65.1 % | -32.61% |
Europe
34.5
%
| 3 | 31.0 % | 2 | 34.5 % | -20.38% |
Foreign
0.4
%
| 0 | 0.0 % | 0 | 0.4 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Lubniewski
CEO | Chief Executive Officer | 60 | 01/11/01 |
Shaun McMeans
DFI | Director of Finance/CFO | 62 | 01/12/01 |
Chief Administrative Officer | 45 | 01/15/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 27/15/27 | |
Director/Board Member | 59 | 27/22/27 | |
Ann Hanham
CHM | Chairman | 71 | 29/16/29 |
Thomas Dubensky
BRD | Director/Board Member | 66 | 18/22/18 |
John Lubniewski
CEO | Chief Executive Officer | 60 | 01/11/01 |
Michelle Griffin
BRD | Director/Board Member | 58 | 16/18/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,214,233 | 2,169,854 ( 98.00 %) | 0 | 98.00 % |
Company contact information
HTG Molecular Diagnostics, Inc.
3430 East Global Loop
85706-5009, Tucson
+877 289 2615
http://www.htgmolecular.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-16.33% | 18.62B | |
+22.02% | 1.94B | |
+0.39% | 1.68B | |
+27.15% | 1.26B | |
-10.70% | 1.03B | |
-18.27% | 938M | |
+0.66% | 783M | |
-25.07% | 628M | |
+14.62% | 535M |
- Stock Market
- Equities
- HTGMQ Stock
- Stock
- Company HTG Molecular Diagnostics Inc